Literature DB >> 18280176

Pericardial malignant mesothelioma: a latent complication of radiotherapy?

Gary R Small1, Marianne Nicolson, Keith Buchan, Paul Broadhurst.   

Abstract

Pericardial diseases can be difficult to differentiate from myocardial conditions. Diagnosis can be challenging and often requires the use of different imaging modalities. Here, we describe a case which presented with common cardiac symptoms which were shown to be the result of a rare condition. A 62-year-old lady presented with left femoral artery embolism. Post-embolectomy she developed cardiac failure. Three months previously an acellular, sterile pericardial effusion had been drained. In 1993 a left mastectomy and axillary node clearance was performed for breast cancer. Adjuvant chemotherapy and radiotherapy were administered. Examination revealed a raised jugular venous pressure (JVP) with rapid Y descent and Kussmaul's sign. CT chest and abdomen found no recurrence of breast carcinoma. Cardiac MRI demonstrated thickened pericardium. At cardiac catheterisation haemodynamic responses consistent with constrictive pericarditis were seen. Pericardiectomy was performed. Histology revealed pericardial epithelioid malignant mesothelioma. 18-FDG-PET CT post-operatively was negative in the pericardium and pleura. Chemotherapy with pemetrexed and carboplatin was given. The patient died 9 months after presentation. Radiotherapy and asbestos exposure are both associated with pericardial mesothelioma and the aetiology in this case was not clear. The condition carries a poor prognosis and is invariable fatal although newer chemotherapeutic regimens have prolonged survival times.

Entities:  

Mesh:

Year:  2008        PMID: 18280176     DOI: 10.1016/j.ejcts.2007.12.024

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  9 in total

1.  Malignant pericardial mesothelioma : A systematic review of current practice.

Authors:  S Cao; S Jin; J Cao; J Shen; H Zhang; Q Meng; B Pan; Y Yu
Journal:  Herz       Date:  2017-01-27       Impact factor: 1.443

2.  Post-irradiation constrictive pericarditis following thymoma treatment: a report of two cases.

Authors:  Yu Hikosaka; Motoki Yano; Shinya Otsuka; Hidefumi Sasaki; Satoru Moriyama; Katsuhiro Okuda; Masayuki Shitara; Yoshitaka Fujii
Journal:  Gen Thorac Cardiovasc Surg       Date:  2013-08-03

3.  Surgical experience of pericardial mesothelioma presenting as constrictive pericarditis.

Authors:  Jung Hee Bang; Mee Sook Roh; Sook Hee Hong; Pill Jo Choi; Jong Soo Woo
Journal:  J Cardiol Cases       Date:  2010-05-05

4.  Pericardial Mesothelioma Presenting as Constrictive Pericarditis.

Authors:  Biraj Shrestha; Rishin Handa; Bidhya Poudel; Rittu Hingorani
Journal:  Cureus       Date:  2022-04-19

5.  Desmoplastic malignant mesothelioma of the pericardium: Description of a case and review of the literature.

Authors:  Antonello Nicolini; Alessandro Perazzo; Sergio Lanata
Journal:  Lung India       Date:  2011-07

6.  18F-fluorodeoxyglucose imaging of primary malignant pericardial mesothelioma with concurrent pericardial and pleural effusions and bone metastasis: A case report.

Authors:  Xiaohui Li; Rugang Lu; Youcai Zhao; Feng Wang; Guoqiang Shao
Journal:  Mol Clin Oncol       Date:  2018-04-12

7.  Response to the "Letter to the Editor" by Gabor Mezei et al., Comments on Vimercati et al., 2019, "Asbestos exposure and malignant mesothelioma of the tunica vaginalis testis: a systematic review and the experience of the Apulia (Southern Italy) mesothelioma register".

Authors:  Luigi Vimercati; Domenica Cavone; Maria Celeste Delfino; Luigi De Maria; Antonio Caputi; Giovanni Maria Ferri; Gabriella Serio
Journal:  Environ Health       Date:  2019-12-26       Impact factor: 5.984

8.  Primary Pericardial Mesothelioma: Report of a Patient and Literature Review.

Authors:  Ase Nilsson; Torgny Rasmuson
Journal:  Case Rep Oncol       Date:  2009-07-29

9.  Post-irradiation pericardial malignant mesothelioma with deletion of p16: a case report.

Authors:  Yalda B Naeini; Ramir Arcega; Sharon Hirschowitz; Nagesh Rao; Haodong Xu
Journal:  Cancer Biol Med       Date:  2018-02       Impact factor: 4.248

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.